Guobang Pharma Ltd. (SHA:605507)
20.38
+0.13 (0.64%)
Jun 6, 2025, 2:45 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
Pharmaceutical | 3.49B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pharmaceutical Growth | -3.57% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Animal Health Products | 1.83B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Animal Health Products Growth | -12.19% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Business | 22.35M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 7.13M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | -58.86% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 7.13M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | -58.86% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
China | 2.87B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
China Growth | -14.23% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Overseas | 2.46B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Overseas Growth | 4.20% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
America | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
America Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|